Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun 1;32(6):1537.
doi: 10.1681/ASN.2021020204. Epub 2021 Apr 13.

On the Increased Event Rate of Urinary Tract Infection and Pneumonia in CKD Patients Treated with Roxadustat for Anemia

Theodoros Eleftheriadis  1 , Georgios Pissas, Vassilios Liakopoulos, Ioannis Stefanidis
Affiliations
Comment

On the Increased Event Rate of Urinary Tract Infection and Pneumonia in CKD Patients Treated with Roxadustat for Anemia

Theodoros Eleftheriadis et al. J Am Soc Nephrol. .
No abstract available

Keywords: T cell; immune response; infection; roxadustat anemia.

PubMed Disclaimer

Comment in

  • Authors' Reply.
    Fishbane S, El-Shahawy MA, Van BP, Little DJ. Fishbane S, et al. J Am Soc Nephrol. 2021 Jun 1;32(6):1537-1538. doi: 10.1681/ASN.2021030334. Epub 2021 Apr 13. J Am Soc Nephrol. 2021. PMID: 33849916 Free PMC article. No abstract available.

Comment on

References

    1. Fishbane S, El-Shahawy MA, Pecoits-Filho R, Van BP, Houser MT, Frison L, et al. .: Roxadustat for treating anemia in patients with CKD not on dialysis: Results from a randomized phase 3 study. J Am Soc Nephrol 32: 737–755, 2021. - PMC - PubMed
    1. Chen N, Hao C, Liu B-C, Lin H, Wang C, Xing C, et al. .: Roxadustat treatment for anemia in patients undergoing long-term dialysis. N Engl J Med 381: 1011–1022, 2019. - PubMed
    1. Akizawa T, Iwasaki M, Yamaguchi Y, Majikawa Y, Reusch M: Phase 3, randomized, double-blind, active-comparator (darbepoetin alfa) study of oral roxadustat in CKD patients with anemia on hemodialysis in Japan. J Am Soc Nephrol 31: 1628–1639, 2020. - PMC - PubMed
    1. Tao J-H, Barbi J, Pan F: Hypoxia-inducible factors in T lymphocyte differentiation and function. A review in the theme: Cellular responses to hypoxia. Am J Physiol Cell Physiol 309: C580–C589, 2015. - PMC - PubMed
    1. Eleftheriadis T, Pissas G, Mavropoulos A, Nikolaou E, Filippidis G, Liakopoulos V, et al. .: In mixed lymphocyte reaction, the hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat suppresses cellular and humoral alloimmunity. Arch Immunol Ther Exp (Warzs) 68: 31, 2020. - PubMed

MeSH terms